ARTIGO: VARIAÇÃO BIOLÓGICA DO ANTÍGENO PROSTÁTICO ESPECÍFICO...
133
13. Morote J, Raventós CX, Lorente JA, Lopez-Pacios MA, Encabo G, de Torres I,
Andreu J. Comparison of percent free prostate specific antigen and prostate
specific antigen density as methods to enhance prostate specific antigen specifity
in early prostate cancer detection in men with normal rectal examination and
prostate specific antigen between 4.1 and 10.0 ng / ml. J Urol, 158:502-9, 1997.
14. Bangma CH, Rietbergen JBW, Kranse R, Blijenberg BG, Petterson K, Schröder
FH. The free-to-total prostate specific antigen ratio improves the specificity of
prostate specific antigen in screening for prostate cancer in the general
population. J Urol, 157: 2191-6, 1997.
15. Tchetgen MB, Oesterling JE. The effect of prostatitis, urinary retention,
ejaculation and ambulation on the serum prostate-specific antigen concentration.
Urol Clin North Am, 24:283-91, 1997.
16. Singh R, Cahill D, et al. Repeating the measurement of prostate-specific antigen
in symptomatic men can avoid unnecessary prostatic biopsy. BJU Int, 92:932-5,
2003.
17. Schaeffer AJ, WU SC, Tennenberg AM, Kahn JB. Treatment of chronic bacterial
prostatitis with levofloxacin and ciprofloxacin lowers serum prostate specific
antigen. J Urol, 174:161-4, 2005.
18. Hammer P, Huland H. Systematic sextant biopsies in 651 pacients referred for
prostate evaluation. J Urol, 151:99-101, 1996.
19. Riehmann M, Rhodes PR, Cook TD, Grose GS, Bruskewitz RC. Analysis of
variation in prostate-specific antigen values. Urology, 42(4):390-7, 1993.
20. Paez A, Lujan M, Raaijmakers R, Berenguer A. Four-year prostate-specific
antigen progression in the non-cancer population of the European Randomized
Study of Screening for Prostate Cancer. BJU Int, 92(2):84-7, 2003.
21. Punglia RS, D'Amico AV, Catalona WJ, Roehl KA, Kuntz KM. Effect of
verification bias on screening for prostate cancer by measurement of prostate-
specific antigen. N Engl J Med, 349(4):335-42, 2003.
22. Lujan M, Paez A, Sanchez E, Herrero A, Martin E, Berenguer A. Prostate specific
antigen variation in patients without clinically evident prostate cancer. J Urol,
162:1311-3, 1999.
23. Carter HB, Pearson JD, Metter JE, Brant LJ, Chan DW, Andres R et al.
Longitudinal evaluation of prostate specific antigen leves in men with and without
prostate disease. JAMA, 267:2215-20, 1992.
24. Kadmon D, Weinberg D, Willians RH, Pavlik VN, Cooper P, Migliore PJ. Pitfalls in
interpreting prostate specific antigen velocity. J Urol, 155:1655-7, 1996.
25. Nixon RG, Wener MH, Smith KM, Parson RE, Strobel SA, Brawer MK. Biological
variation of prostate specific antigen levels in serum: an evaluation of day-to-day
physiological fluctuations in a well-defined cohort of 24 patients. J Urol,
157:2183-90, 1997.